Carderock Capital Management Inc Lowers stake in Henry Schein (HSIC)

Henry Schein (HSIC) : Carderock Capital Management Inc reduced its stake in Henry Schein by 8.64% during the most recent quarter end. The investment management company now holds a total of 30,638 shares of Henry Schein which is valued at $5,069,363 after selling 2,898 shares in Henry Schein , the firm said in a disclosure report filed with the SEC on Aug 15, 2016.Henry Schein makes up approximately 2.62% of Carderock Capital Management Inc’s portfolio.

Other Hedge Funds, Including , D. E. Shaw reduced its stake in HSIC by selling 15,992 shares or 92.08% in the most recent quarter. The Hedge Fund company now holds 1,376 shares of HSIC which is valued at $227,673.Oppenheimerfunds boosted its stake in HSIC in the latest quarter, The investment management firm added 13,151 additional shares and now holds a total of 154,750 shares of Henry Schein which is valued at $25,604,935. Henry Schein makes up approx 0.03% of Oppenheimerfunds’s portfolio.Buffington Mohr Mcneal reduced its stake in HSIC by selling 750 shares or 8.61% in the most recent quarter. The Hedge Fund company now holds 7,960 shares of HSIC which is valued at $1,329,002. Henry Schein makes up approx 0.57% of Buffington Mohr Mcneal’s portfolio.Meeder Asset Management Inc reduced its stake in HSIC by selling 927 shares or 33.3% in the most recent quarter. The Hedge Fund company now holds 1,857 shares of HSIC which is valued at $335,486. Henry Schein makes up approx 0.03% of Meeder Asset Management Inc’s portfolio.Ibm Retirement Fund reduced its stake in HSIC by selling 165 shares or 1.67% in the most recent quarter. The Hedge Fund company now holds 9,704 shares of HSIC which is valued at $1,753,125. Henry Schein makes up approx 0.06% of Ibm Retirement Fund’s portfolio.

Henry Schein closed down -0.81 points or -0.49% at $162.98 with 3,41,373 shares getting traded on Thursday. Post opening the session at $163.92, the shares hit an intraday low of $162.28 and an intraday high of $164.31 and the price fluctuated in this range throughout the day.Shares ended Thursday session in Red.

On the company’s financial health, Henry Schein reported $1.64 EPS for the quarter, beating the analyst consensus estimate by $ 0.01 according to the earnings call on Aug 4, 2016. Analyst had a consensus of $1.63. The company had revenue of $2872.60 million for the quarter, compared to analysts expectations of $2845.09 million. The company’s revenue was up 9.3% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.46 EPS.

Henry Schein Inc. provides health care products and services to office-based dental animal health and medical practitioners. The Company operates its business through two segments: health care distribution and technology and value-added services. The health care distribution segment distributes consumable products laboratory products equipment repair services branded and generic pharmaceuticals vaccines surgical products diagnostic tests infection-control products and vitamins among others. The Company’s global technology and value-added services segment provides software technology and other value-added services to health care practitioners. Its offerings include practice management software systems for dental and medical practitioners and animal health clinics. Its value-added practice solutions include financial services on a non-recourse basis e-services practice technology network and hardware services as well as continuing education services for practitioners.

Leave a Reply

Henry Schein - Is it time to Sell?

Top Brokerage Firms are advising their investors on Henry Schein. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.